Form 8-K - Current report:
SEC Accession No. 0001140361-24-041566
Filing Date
2024-09-20
Accepted
2024-09-20 16:15:19
Documents
14
Period of Report
2024-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20036097_8k.htm   iXBRL 8-K 30227
2 EXHIBIT 3.1 ef20036097_ex3-1.htm EX-3.1 8102
  Complete submission text file 0001140361-24-041566.txt   179696

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcpc-20240918.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcpc-20240918_lab.xml EX-101.LAB 22691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcpc-20240918_pre.xml EX-101.PRE 16550
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20036097_8k_htm.xml XML 4217
Mailing Address 5 PARAGON DRIVE MONTVALE NJ 07645
Business Address 5 PARAGON DRIVE MONTVALE NJ 07645 (845) 326-5600
BALCHEM CORP (Filer) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13648 | Film No.: 241313554
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)